We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MPLX:NYSEMPLX LP Analysis

Data as of 2026-07-16 - not real-time

$56.41

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

MPLX is trading at $56.41, comfortably above its 20‑day SMA of 56.70 and 50‑day SMA of 56.09, while still below the 200‑day SMA of 54.88, indicating a short‑term bullish bias within a longer‑term uptrend. The RSI sits at 48.5, suggesting neutral momentum, and the MACD histogram has turned negative (-0.053) with a bearish signal line crossover, flagging a potential short‑term pullback toward the identified support at $55.37. Volume is trending lower, which could limit upside momentum but also reduces downside pressure given the strong cash‑flow profile. On the valuation side, MPLX’s trailing PE of 12.2 is well below the industry average of 21.0, and the forward PE of 11.5 reinforces a discount relative to peers, supporting an undervalued view. The company delivers a robust 7.63% dividend yield with a payout ratio of 88%, and free cash flow of roughly $1.93 bn underpins the sustainability of distributions. Despite a modest revenue decline of -2.8%, operating margins remain healthy (>36%) and ROE is an impressive 33%, reflecting efficient asset utilization. However, the balance sheet is leveraged, with a debt‑to‑equity ratio near 183, a factor that investors must monitor as interest‑rate environments evolve. The stock’s beta of 0.45 and 30‑day volatility of 16.7% indicate lower market sensitivity, and the current “Extreme Greed” sentiment (fear‑greed index 92) adds a bullish flavor to the short‑term outlook. Overall, the combination of attractive yield, undervalued multiples, and solid cash generation suggests MPLX is positioned for steady income and modest capital appreciation, provided leverage remains manageable.
In the near term, the price is testing the $55.37 support and could bounce if buying interest returns, while the bearish MACD warns against aggressive entry. Medium‑term prospects are bolstered by upcoming natural‑gas and NGL projects moving into service in H2 2026, which should lift fee‑based earnings. Long‑term investors should weigh the high dividend against the elevated debt load, but the company’s stable cash flows and sector‑tailwinds support a buy‑and‑hold narrative for income‑focused portfolios.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at $55.37
  • Bearish MACD crossover
  • High dividend yield offering income cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to industry
  • Strong operating margins and ROE
  • Upcoming midstream projects entering service

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated debt‑to‑equity ratio
  • Sustainable cash flow supporting dividend
  • Sector tailwinds in oil & gas midstream

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin40.03%
P/E Ratio12.2
ROE33.41%
ROA7.04%
Debt/Equity182.79
P/B Ratio4.1
Op. Cash Flow$6.0B
Free Cash Flow$1.9B
Industry P/E21.0

Technical Analysis

TrendBullish
RSI48.5
Support$55.37
Resistance$58.08
MA 20$56.70
MA 50$56.09
MA 200$54.88
MACDBearish
VolumeDecreasing
Fear & Greed Index92.09

Valuation

Fair Value$0.45
Target Price$60.86
Upside/Downside7.88%
GradeUndervalued
TypeValue
Dividend Yield7.63%

Risk Assessment

Beta0.02
Volatility16.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.